0.525
-0.03 (-5.98%)
| Previous Close | 0.559 |
| Open | 0.558 |
| Volume | 269,896 |
| Avg. Volume (3M) | 7,024,096 |
| Market Cap | 15,818,919 |
| Price / Earnings (TTM) | 1.09 |
| Price / Sales | 290.88 |
| 52 Weeks Range |
| Operating Margin (TTM) | -9,671.16% |
| Diluted EPS (TTM) | 0.480 |
| Current Ratio (MRQ) | 0.710 |
| Operating Cash Flow (TTM) | -9.61 M |
| Levered Free Cash Flow (TTM) | -8.49 M |
| Return on Assets (TTM) | -84.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Bearish | Bearish |
| Household & Personal Products (Global) | Bearish | Mixed | |
| Stock | Carmell Corporation | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -1.63 |
|
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| % Held by Insiders | 33.66% |
| % Held by Institutions | 19.49% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Hubbell Strickland Wealth Management, Llc | 31 Dec 2024 | 205,222 |
| Carnegie Mellon University | 30 Sep 2024 | 134,469 |
| Bangor Savings Bank | 31 Dec 2024 | 34,608 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Jan 2025 | Announcement | Carmell Announces Closing of Elevai Skincare Acquisition |
| 03 Jan 2025 | Announcement | Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out |
| 02 Jan 2025 | Announcement | Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products |
| 24 Dec 2024 | Announcement | Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |